Verition Fund Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,460
Closed -$388K 3428
2025
Q4
$388K Buy
18,460
+1,281
+7% +$22.3K ﹤0.01% 2848
2025
Q3
$264K Sell
17,179
-108,166
-86% -$1.42M ﹤0.01% 3357
2025
Q2
$1.17M Buy
125,345
+90,308
+258% +$994K 0.01% 2355
2025
Q1
$430K Buy
+35,037
New +$494K ﹤0.01% 2672
2024
Q4
Sell
-79,341
Closed -$1.53M 3502
2024
Q3
$1.53M Sell
79,341
-65,225
-45% -$1.35M 0.01% 1594
2024
Q2
$2.97M Sell
144,566
-202,296
-58% -$4.23M 0.02% 1040
2024
Q1
$8.26M Buy
346,862
+203,596
+142% +$4.54M 0.06% 409
2023
Q4
$3.1M Buy
143,266
+128,266
+855% +$1.97M 0.02% 632
2023
Q3
$218K Buy
+15,000
New +$284K ﹤0.01% 1931
2022
Q4
Sell
-10,737
Closed -$258K 2681
2022
Q3
$258K Buy
+10,737
New +$241K ﹤0.01% 2334
2021
Q1
Sell
-88,595
Closed -$1.97M 1752
2020
Q4
$1.97M Buy
+88,595
New +$1.84M 0.02% 378

Other funds holding SNDX